Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Chargeback Fraud Detection: 3 Methods To Reduce Disputes and Chargeback Costs

24/02/2023Chargeback Fraud Detection: 3 Methods To Reduce Disputes and Chargeback Costs

Do you know that for every $1 lost to chargebacks, stakeholders lose $4.23 on average? Little wonder eCommerce businesses dread chargebacks; it is not only costly, it is time-consuming.

HOSTMAKER launches Bangkok branch

13/08/2018HOSTMAKER launches Bangkok branch

HOSTMAKER, the leading home rental management company in Europe, has today announced its launch into the Asian market, expanding into Bangkok, the world's most visited city.

Bad First Impressions Drive One-Third of Consumers to Delete Apps

03/12/2020Bad First Impressions Drive One-Third of Consumers to Delete Apps

ForgeRock®, the leading provider in digital identity, today announced the release of volume two of its global report, “The New Normal – Living Life Online.” The study polled 5,000 consumers throughout the U.S., U.K., Germany, Australia and Singapore to

Planning to Sell or Exit a Business? Here’s What You Need to Know About Succession Planning

05/10/2023Planning to Sell or Exit a Business? Here’s What You Need to Know About Succession Planning

When considering exiting or selling your business, there are two key things to consider; succession planning and preparing your business for sale.

How to Transform Retail Customer Experience with VR

08/06/2023How to Transform Retail Customer Experience with VR

Each year, the number of customers ready to make purchases with VR is growing, even in the premium segment of the retail market. According to June 2022 Global Consumer Insights Pulse Survey by PWC, 19% of consumers used VR to purchase luxury goods.

Employees: This Is How Tax Fraud Affects your Background Check in 2021

04/06/2021Employees: This Is How Tax Fraud Affects your Background Check in 2021

Paying taxes and filing returns is an important civic responsibility. While some employers may fail to make a background check on tax fraud, you wouldn't want to be on the wrong side of the law. Tax fraud occurs when you knowingly forge information on tax retu

Russia’s investment will ensure stable supply of Russian crude through 2021

02/02/2018Russia’s investment will ensure stable supply of Russian crude through 2021

Russia’s investment will ensure stable supply of Russian crude through 2021

Fashion Takeover

30/07/2015Fashion Takeover

Reed Smith advises BlueBay and Lloyds on Silverfleet’s acquisition of Masai Clothing.

How Can CFOs Help Businesses Navigate the Pandemic

07/09/2021How Can CFOs Help Businesses Navigate the Pandemic

The global spread of COVID-19 has had some drastic effects on the way businesses function. This article highlights steps CFOs can take across three major sectors: immediate recovery, short-term stability, and long-term improvements.

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS